Molecular Templates (MTEM) News Today $0.16 -0.19 (-54.29%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Nasdaq to file Form 25-NSE with SEC to delist Molecular TemplatesDecember 20 at 9:33 AM | markets.businessinsider.comMolecular Templates Faces Delisting from NasdaqDecember 20 at 4:13 AM | americanbankingnews.comMolecular Templates, Inc. Faces Delisting from Nasdaq Due to Compliance IssuesDecember 19 at 4:46 PM | quiverquant.comMolecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing RulesDecember 19 at 4:10 PM | globenewswire.comMolecular Templates Announces Key Leadership TransitionDecember 4, 2024 | markets.businessinsider.comMolecular Templates, Inc. Receives Nasdaq Deficiency Notification for Reporting and Bid Price ComplianceDecember 2, 2024 | quiverquant.comMolecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price RequirementsDecember 2, 2024 | globenewswire.comTarget N. V. Biotech Sells 1,279,820 Shares of Molecular Templates, Inc. (NASDAQ:MTEM) StockNovember 19, 2024 | insidertrades.comWhy Molecular Templates (MTEM) Stock Is Down 77% TodayOctober 14, 2024 | benzinga.comMolecular Templates Approves Liquidation, Wind Up of CompanyOctober 11, 2024 | marketwatch.comStocks to Watch: Boeing, Vera Bradley, Molecular TemplatesOctober 11, 2024 | marketwatch.comMolecular Templates (NASDAQ:MTEM) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comTemplate synthesis creates multilayered perovskites with unique ferroelectric behaviorSeptember 18, 2024 | msn.comMolecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate UpdateAugust 14, 2024 | globenewswire.comMolecular Templates, Inc. Provides Interim UpdateJune 3, 2024 | globenewswire.comMTEM Stock Earnings: Molecular Templates Beats EPS, Beats Revenue for Q1 2024May 16, 2024 | investorplace.comMolecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate UpdateMay 15, 2024 | finance.yahoo.comMolecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate UpdateMay 15, 2024 | globenewswire.comMolecular Templates (NASDAQ: MTEM)May 2, 2024 | fool.comMolecular Templates reports progress in cancer therapy trialApril 11, 2024 | uk.investing.comMTEM Stock Earnings: Molecular Templates Beats EPS, Misses Revenue for Q4 2023April 11, 2024 | msn.comWhat's Going On With Molecular Templates Stock?April 9, 2024 | msn.comMolecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology MechanismApril 9, 2024 | globenewswire.comTarget N. V. Biotech Acquires 250,000 Shares of Molecular Templates, Inc. (NASDAQ:MTEM) StockApril 5, 2024 | insidertrades.comMolecular Templates GAAP EPS of -$0.73, revenue of $7.02MMarch 29, 2024 | msn.comMolecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business UpdateMarch 29, 2024 | globenewswire.comMolecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase AgreementMarch 28, 2024 | globenewswire.comMolecular Templates, Inc. Provides Interim UpdateMarch 4, 2024 | finance.yahoo.comMolecular Templates, Inc. Provides Interim UpdateMarch 4, 2024 | globenewswire.comMolecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceFebruary 8, 2024 | finance.yahoo.comTrading was temporarily halted for "MTEM" at 09:12 AM with a stated reason of "LULD pause."December 18, 2023 | marketbeat.comTrading was temporarily halted for "MTEM" at 02:12 PM with a stated reason of "LULD pause."December 11, 2023 | marketbeat.comMolecular Templates Inc MTEMDecember 6, 2023 | morningstar.comMolecular Templates GAAP EPS of -$0.82 beats by $1.13, revenue of $6.8M beats by $4.34MNovember 13, 2023 | msn.comMolecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business UpdateNovember 13, 2023 | finance.yahoo.comMolecular Templates to Participate in Upcoming Investor ConferencesNovember 1, 2023 | finance.yahoo.comMolecular Templates appoints Maurizio Voi as chief medical officerSeptember 30, 2023 | seekingalpha.comMolecular Templates, Inc.: Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical OfficerSeptember 30, 2023 | finanznachrichten.deMolecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical OfficerSeptember 28, 2023 | finance.yahoo.comMolecular Templates (MTEM) Price Target Increased by 1400.00% to 38.25August 31, 2023 | msn.comMolecular Templates, Inc.: Molecular Templates Announces 1-for-15 Reverse Stock SplitAugust 11, 2023 | finanznachrichten.deMolecular Templates Announces 1-for-15 Reverse Stock SplitAugust 11, 2023 | finance.yahoo.comMolecular Templates GAAP EPS of -$0.19 beats by $0.15, revenue of $6.87M beats by $4.29MAugust 10, 2023 | msn.comMolecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business UpdateAugust 10, 2023 | finance.yahoo.comAfter layoffs, Molecular Templates overhauls C-suiteAugust 4, 2023 | finance.yahoo.comMolecular Templates launches $40M private placementJuly 13, 2023 | seekingalpha.comMolecular Templates (MTEM) Price Target Decreased by 76.19% to 2.55July 6, 2023 | msn.comMolecular Templates Announces the FDA Removal of Partial Clinical Hold in the Phase 1 Clinical Trial for MT-0169 and Focuses on Extramedullary MyelomaJune 1, 2023 | finance.yahoo.comImproved Revenues Required Before Molecular Templates, Inc. (NASDAQ:MTEM) Stock's 45% Jump Looks JustifiedApril 17, 2023 | finance.yahoo.comMolecular Templates, Inc.: Molecular Templates Announces Partial Clinical Hold for Phase 1 Study of MT-0169April 11, 2023 | finanznachrichten.de Get Molecular Templates News Delivered to You Automatically Sign up to receive the latest news and ratings for MTEM and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now MTEM Media Mentions By Week MTEM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MTEM News Sentiment▼0.370.60▲Average Medical News Sentiment MTEM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MTEM Articles This Week▼40▲MTEM Articles Average Week Get Molecular Templates News Delivered to You Automatically Sign up to receive the latest news and ratings for MTEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMGN News Today VRTX News Today GILD News Today REGN News Today ALNY News Today BIIB News Today UTHR News Today NBIX News Today INCY News Today BMRN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MTEM) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Templates, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Templates With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.